Engineering Stem Cells for Cancer Treatment and Infection

A special issue of Bioengineering (ISSN 2306-5354). This special issue belongs to the section "Regenerative Engineering".

Deadline for manuscript submissions: 28 February 2025 | Viewed by 119

Special Issue Editors


E-Mail Website
Guest Editor
Department of Radiation Oncology, University of Kansas Medical Center, Kansas City, KS 66160, USA
Interests: radiation oncology; radiation therapy; GI-ARS; cell therapy

E-Mail Website
Guest Editor
Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern California, Los Angeles, CA, USA
Interests: host-pathogen interactions; antimicrobial resistance

Special Issue Information

Dear Colleagues,

The integration of stem cell engineering into cancer treatment represents a groundbreaking advancement in bioengineering, offering new avenues for targeted and personalized therapy. 

This Special Issue of Bioengineering explores the latest innovations in engineering stem cells for cancer treatment and microbial infection. It covers diverse stem cell types, including embryonic, induced pluripotent, adult mesenchymal, and cancer stem cells, each with distinct advantages and challenges. Advanced genetic engineering techniques like CRISPR/Cas9 are revolutionizing the enhancement of stem cell functionalities for therapeutic purposes. 

This issue highlights innovative modalities such as stem cell-mediated delivery of therapeutic agents, immune-modulating strategies, and the potential of stem cells to combat microbial infections alongside cancer. Advanced genetic engineering techniques like CRISPR/Cas9 are revolutionizing the enhancement of stem cell functionalities for therapeutic purposes. This issue highlights innovative modalities such as stem cell-mediated delivery of therapeutic agents, immune-modulating strategies, and the potential of stem cells to combat microbial infections alongside cancer. Notably, during radiation treatment, the risk of cancer necrosis can lead to microbial infections, creating additional complexities in patient care. The interactions between engineered stem cells, the tumor microenvironment, and microbial pathogens are explored, offering insights into mechanisms of action and the potential for tumor eradication and infection control.

By addressing both cancer and microbial challenges, this Special Issue aims to foster collaboration and inspire further innovation, serving as a valuable resource for researchers, clinicians, and bioengineers dedicated to advancing therapy through cutting-edge science and technology, ultimately enhancing patient outcomes.

Dr. Rishi Man Chugh
Dr. Rajnikant Sharma
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Bioengineering is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • stem cell engineering
  • cancer therapy
  • tumor microenvironment
  • immunotherapy

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop